Patrick Hsu

Overview

Patrick Hsu is an American bioengineer, entrepreneur, and angel investor specializing in CRISPR, machine learning, synthetic biology, and gene therapy. He serves as an assistant professor of bioengineering at the University of California, Berkeley, and co-founded the Arc Institute, a nonprofit research organization focused on accelerating biomedical discovery. Hsu's research has been recognized by awards from the New York Times, The Atlantic, Forbes, MIT Technology Review, Rainwater Foundation, and Amgen. In addition to his academic and research roles, Hsu has co-founded multiple biotech companies, including Stylus Medicine and Terrain Biosciences. He has also been an angel investor in several startups, such as Varda Space Industries and Cradle Bio. In September 2025, he joined Thrive Capital as a venture partner, continuing his involvement in advancing healthcare and technology innovations. Hsu's work bridges biology and machine learning to advance human health, with significant contributions to CRISPR-based genome editing, machine learning, synthetic biology, and gene therapy. His lab focuses on AI foundation models for biology and developing gene editing technologies, with over 65,000 citations to his research.

Investment Focus

• Innovative healthcare and technology solutions
• Strong scientific and technical teams
• Scalable business models
• Potential for significant impact in the healthcare sector
• Alignment with Hsu's expertise in bioengineering and machine learning

Portfolio Companies